Indian biosimilars guidelines go on stream amid implementation concerns
This article was originally published in Scrip
Executive Summary
India is set to implement its first set of guidelines on biosimilars next month, lending much-needed clarity to the approval pathway for such products, though concerns persist on whether the country's regulatory machinery is geared to implement these effectively.